Le cluster Lymphoma, Non-Hodgkin (radiotherapy) - Yttrium Radioisotopes (therapeutic use)
| 000038 (2007) | A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study. | |
| 000041 (2005) | The role of imaging with (111)In-ibritumomab tiuxetan in the ibritumomab tiuxetan (zevalin) regimen: results from a Zevalin Imaging Registry. | |
| 000076 (1996) | Radiation absorbed dose from indium-111-CYT-356. | |
| 000049 (2002) | Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan for patients with relapsed CD20+ B-cell non-Hodgkin's lymphoma. | |
| 000046 (2004) | Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma. | |
| 000051 (2002) | Noninvasive monitoring of somatostatin receptor type 2 chimeric gene transfer. | |
| 000052 (2002) | From the Food and Drug Administration. | |
| 000070 (1997) | Regional differences in gastric acidity and antacid distribution: is a single pH electrode sufficient? | |
| 000078 (1996) | Inhibition of renal uptake of indium-111-DTPA-octreotide in vivo. | |
| 000083 (1995) | Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). | |
| 000115 (1986) | Metabolism and possible health effects of aluminum. |
| This area was generated with Dilib version V0.5.76. |  |